FABP3 and peripheral arterial disease: Based on these data, serum FABP3 may be a valuable diagnostic biomarker that aids first-line physicians and healthcare practitioners with the timely screening of patients for PAD, assessing the severity and extent of the disease, and guiding decision-making regarding medical therapy.